On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of ...

Discover investment opportunities in Rezolute, Inc. as new drug ersodetug advances in phase 3 HI trials, with catalysts ...

While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 ...

Alzheimer’s disease has proved to be a tricky target, and researchers and drug developers have been pursuing effective ...

Monte Rosa Therapeutics stock surged after expanding its Novartis partnership. Click here to learn about their innovative ...

For example, St. John’s wort can interfere with how medicines are metabolized in the liver, while ginseng and ephedra may ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Higher activity of PGC-1α enables brown fat cells in females to thermogenic activity and energy expenditure compared to males ...

A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation—and pointing ...

If there's one thing that's crystal clear about Alzheimer's disease, it's this: It eats away at neurons and the links between ...

Taste receptors are specialized proteins that facilitate the sense of taste. There are different groups of receptors for ...

At ESAD 2025, researchers reported that Viperin (RSAD2) is strongly induced by inflammatory cytokines in pancreatic beta cells and islets.